Återköp av aktier i AstraZeneca

ÅTERKÖP AV AKTIER I ASTRAZENECA PLC AstraZeneca PLC meddelar att företaget den 18 juni 2004 återköpte 700.000 aktier i AstraZeneca PLC till ett pris av 2568 pence per aktie. Aktierna kommer att annulleras. Antalet utestående aktier efter annullering kommer att vara 1.675.421.849. G H R Musker Styrelsens sekreterare 21 juni 2004 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/06/21/20040621BIT00080/wkr0001.pdf

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe

Documents & Links